CellaVision, Lund, Sweden has obtained FDA clearance to introduce its DiffMaster(TM) Octavia, an in-vitro diagnostic device, on the U.S. market. DiffMaster Octavia is an automated cell-locating device for differential count of white blood cells and characterization of red morphology, today conducted through manual microscopy. It is based on a...

CellaVision signs Letter of Intent with Sysmex CellaVision AB (situated in Sweden) and Sysmex Europe GmbH (situated in Germany) have signed a Letter of Intent regarding distribution of CellaVision's products in selected countries, including...